MIT researchers develop enhanced cancer vaccine boosting T cell response

MIT engineers have introduced a novel method to enhance T-cell responses in mRNA vaccines, potentially resulting in more potent cancer vaccines and improved defenses against infectious diseases. Typically, vaccines stimulate antibodies and T cells by activating antigen-presenting cells like dendritic cells. This research, however, fortified the T-cell response using a new vaccine adjuvant. These adjuvants…

Read More